coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Lmn PCN, Dartford · Health Inequalities Profile

    PCN U74266 · NHS Kent and Medway Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    25,790

    Registered population

    54.4% aged 18–64

    26.3%

    Aged 65+

    ICB 19.9% · England 17.9%

    6.3%

    Ethnic minority (non-White)

    2.9% Asian · England 9.6%

    0.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~135

    Core20 residents (est.)

    Resident basis; registered basis ~132 · see page 3

    4,474

    Hypertension register

    +2.63% in 3 yrs · England +5.60%

    164

    SMI register

    14.8% of Dartford's

    428

    COPD register

    Reviews -9.60% in 3 yrs

    Forecast to 2030

    4,773

    Hypertension patients, 2030

    +299 on today

    94.4%

    QRISK ≥20% on statins, 2030

    +11.97pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    48.7%
    Asthma review coverage dropped sharply over three years.

    Annual reviews reached 48.7% (England 65.7%) after falling 28.3% over 2023 to 2025, leaving 769 of 1,500 register patients unreviewed.

    -10.5%
    COPD and dementia registers contracted against national growth.

    Over 2023 to 2025, COPD prevalence fell 10.5% to 1.7% (England +2.6%) and dementia fell 4.3% to 1.2% (England +6.0%), warranting coding review.

    71.5%
    Under-80 hypertension control and SMI checks outpace England.

    Under-80 blood pressure control reached 71.5% (+12.7 pp over 2023 to 2025; England 67.8%), while SMI blood pressure and BMI checks reached 85.2%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 26.3% of registrations, exceeding borough and England benchmarks

    LMN PCN serves 25,790 registered patients, of whom 26.3% (6,778 patients) are aged 65+, above Dartford (15.1%), NHS Kent and Medway ICB (19.9%), and England (17.9%). By practice, Jubilee Medical Centre records 27.5% aged 65+ and Meopham Medical Centre records 24.4%. Census resident data indicates 93.7% are White (Dartford 74.5%, ICB 88.6%, England 81.1%), with a 6.3% ethnic minority share. Projected population growth to 2030 is 0.8% under an unverified method, trailing Dartford (9.1%), the ICB (6.0%), and England (2.3%).

    Age profile

    0–1719.3%
    18–6454.4%
    65+26.3%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White93.7%
    Asian2.9%
    Mixed1.5%
    Black1.1%
    Other0.7%

    Older people · falls rows are Dartford local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Dartford LA)2,0062,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Dartford LA)1,0009819552024/25
    Falls deaths, all ages, per 100,000 (Dartford LA)14.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.5% across the PCN and concentrated entirely at Jubilee Medical Centre

    LMN PCN records an average IMD decile of 7.1, compared to 6.0 in Dartford, 5.4 in NHS Kent and Medway ICB, and 5.5 in England. Its Core20 share is 0.5%, sitting below Dartford (9.8%), the ICB (17.1%), and England (21.0%). Workload is concentrated at Jubilee Medical Centre (0.8% share; 132 estimated patients), whereas Meopham Medical Centre records 0.0%. Resident modelling indicates 135 people across 1 decile-2 LSOA. With Core20 prevalence well below benchmarks, outreach could focus on the small cohort concentrated at the single affected practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Jubilee0.8% · 132 patients
    Meopham0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    164

    SMI register

    0.64% recorded prevalence

    124

    Learning disability register

    0.48% recorded prevalence

    12

    Care homes, 454 beds

    In the PCN catchment

    8.6%

    Provide unpaid care

    Dartford, Census 2021

    The PCN records 124 learning disability patients (0.5%) and 164 severe mental illness patients (0.6%), alongside 12 catchment care homes with 454 beds. Both registers trail Dartford (0.6% and 0.8%), NHS Kent and Medway ICB (0.6% and 0.9%), and England (0.6% and 1.0%). Crude prevalence differences do not establish under-detection, but may prompt review of diagnostic recording across practices.

    Severe mental illness: physical health checks

    Annual SMI checks show BP (85.2%) and BMI (85.2%) above England (83.4% and 82.1%). Smoking cessation support fell 2.2 pp over 2023 to 2025 (England +0.1 pp) to 96.5%, dipping to 90.4% at Meopham Medical Centre.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,474

    Hypertension register

    +2.63%

    Register growth, 3 yrs

    Dartford +7.12% · England +5.60%

    +12.66pp

    BP control, under 80

    ≤140/90 · +3.13pp aged 80+

    +299

    More patients by 2030

    Forecast 4,773 (18.26%)

    Hypertension case-finding and control

    Hypertension register prevalence is 17.3% (4,474 patients), above England (15.2%), Dartford (15.9%), and NHS Kent and Medway ICB (16.2%). Blood pressure monitoring reached 92.0% (England 90.0%). For patients aged under 80, blood pressure control was 71.5% after a 12.7 pp rise over 2023 to 2025 (England +2.1 pp). For patients aged 80 and over, control was 78.1%, below England (81.2%), Dartford (79.0%), and NHS Kent and Medway ICB (78.3%), with Jubilee Medical Centre recording 77.0% and Meopham Medical Centre recording 80.3%. Blood pressure control among patients aged 80 and over trails national and local benchmarks across both member practices.

    Lipids and statins

    Lipid-lowering therapy coverage is 60.9% for patients with QRISK ≥ 20% (England 63.6%, Dartford 64.2%, NHS Kent and Medway ICB 61.4%) and 68.5% for patients with CKD (England 70.3%, Dartford 74.3%, NHS Kent and Medway ICB 69.2%). Secondary prevention treatment rates trail national benchmarks in both high-risk cardiovascular cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202652,846£1.50£1.90£1.86£79,269
    Cardiovascular (all), 202568,267£3.78£3.57£3.33£258,049

    In 2026, the PCN prescribed 52,846 items for lipid-regulating drugs at £1.50 per item, below England (£1.86), Dartford (£1.79), and NHS Kent and Medway ICB (£1.90), spending £19,025 less than at England's unit cost across 52,846 items. Prescribing unit costs remain lower than comparators, though unit cost does not measure treatment appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −28.33%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.01%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 19.3 pp (a 28.3% relative drop) over 2023 to 2025 to 48.7%, trailing Dartford (60.8%) and England (65.7%), leaving about 770 of 1,500 registered patients unreviewed; Jubilee Medical Centre achieved 40.0% while Meopham Medical Centre reached 63.2%. Over 2023 to 2025, COPD reviews fell 9.6% to 74.8% (England +2.8%), while COPD prevalence contracted 10.5% to 1.7% (England +2.6%).

    Cancer register and children's immunisation

    Cancer prevalence is 5.6% (1,456 patients), above Dartford (3.3%) and England (3.8%). In Q1 2025/26, 6-in-1 coverage at 24 months reached 98.3% (England 92.2%). At age 5, coverage was 87.9% across MMR dose 1, MMR dose 2, and the 4-in-1 pre-school booster (cohort of 58 children), each sitting 7.1 pp below the 95.0% target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.7%

    England 91.0%

    6-in-1 complete primary course at 24 months98.3%

    England 92.2%

    MMR dose 1 at 24 months89.7%

    England 88.3%

    MMR dose 2 at age 587.9%

    England 82.8%

    4-in-1 pre-school booster at age 587.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    LMN PCN recorded 5.6% cancer prevalence (1,456 patients), with three-year growth of +5.8% over 2023 to 2025 (England +9.0%). Cervical screening reached 75.6% (Meopham Medical Centre 78.2%, Jubilee Medical Centre 73.9% vs England 66.8%) and breast screening reached 77.5% (England 69.9%). Across NHS Kent and Medway ICB in 2022, 55.6% of cancers were diagnosed at stage 1 or 2 (4,661 of 8,384 staged cancers; England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028, requiring 1,627 extra early diagnoses annually. Staging data is ICB-level with 63.6% known-stage completeness (England 67.0%), not PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Dartford and Gravesham NHS Trust achieved 63.6% on the 62-day cancer standard (21.4 pp below the 85.0% standard), trailing Medway NHS Foundation Trust (81.6%), NHS Kent and Medway Integrated Care Board (75.9%), and England (71.2%). Faster diagnosis (28-day FDS) reached 78.1% (England 79.3%) and 31-day combined treatment was 97.5% (England 92.5%). Diagnostic tests waiting 6+ weeks reached 8.4% (England 23.1%), with colonoscopy at 0.4%, non-obstetric ultrasound at 10.9%, and cystoscopy at 19.0%. These acute waiting times describe provider performance, not PCN performance.

    Pathways within standard (%)Dartford and GraveshamMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1477.7776.7879.32
    31-day treatment (96%)97.4899.6295.8492.50
    62-day referral to treatment (85%)63.5981.6475.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthMedwayEngland
    MRI0.36—0.6821.40
    CT2.08—0.009.92
    Echocardiography3.90—36.6228.48
    Colonoscopy0.40—1.8830.83
    Gastroscopy0.00—3.3229.02
    All 15 DM01 tests8.3727.4914.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026, Kent residents recorded 265,905 community care activities, 210,170 care contacts (65.8% with adults aged 65+), and 59,360 referrals across 60,605 active patients; NHS Kent and Medway Integrated Care Board recorded 297,595 activities and 254,055 contacts. These experimental figures describe wider system activity, not confirmed PCN patient volume.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access diverges by 30.2 percentage points between practices alongside vaccination lags

    In 2025/26, QOF overall achievement reached 93.8% at Jubilee Medical Centre and 93.9% at Meopham Medical Centre (England 92.5%). Vaccination and immunisation achievement trailed England (55.2%) at 45.0% at Jubilee Medical Centre and 50.2% at Meopham Medical Centre (a 5.2 pp range). Vaccination personalised care adjustments were 7.4% at Jubilee Medical Centre and 4.4% at Meopham Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Meopham900.051.3%79.2%82.0%
    Jubilee1120.821.2%75.4%63.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNDartfordAssetPCNDartford
    Care homes (catchment)12 (454 beds)n/aSchools (catchment)44n/a
    Children's centres27Places of worship2641
    Libraries67Homelessness support (VCS)n/a1
    Day centres (VCS)55Children and young people (VCS)n/a1
    Carers support groups (VCS)13Primary schools (LA maintained)76
    Primary academies622Special schools1no data

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall recovery

    Asthma review coverage is 48.7% (Dartford 60.8%, England 65.7%) after a 28.3% drop over 2023 to 2025, leaving 769 of 1,500 registered patients unreviewed. For discussion: practices could run a structured asthma review recall using a single template and flexible slots, prioritising Jubilee Medical Centre. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    COPD register and review audit

    COPD prevalence is 1.7% (428 patients; Dartford 1.6%, England 1.9%; Range -12 to +61) after a 10.5% drop over 2023 to 2025; reviews fell 9.6% to 74.8% (England 76.4%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.5% (124 patients; +10.1% over 2023 to 2025), below Dartford, ICB, and England (each 0.6%), with a modelled gap of Range +21 to +28. For discussion: practices could validate learning disability coding and cross-check registers with social-care or special-school records where data sharing exists. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult anticipatory care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 case-finding (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation support audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertension control audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster and MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register and pathway review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephony and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall recovery (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · COPD register and review audit (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15